Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Gemcitabine”

2,285 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 2,285 results

Early research (Phase 1)Study completedNCT03883919
What this trial is testing

Liposomal Irinotecan Plus 5-FU / LV Combined With Paricalcitol in Patients With Advanced Pancreatic Cancer Progressed on Gemcitabine-based Therapy

Who this might be right for
Pancreatic CancerPancreas CancerCancer of the Pancreas
Washington University School of Medicine 20
Early research (Phase 1)Study completedNCT02620800
What this trial is testing

Study of 5-fluorouracil (5-FU), Nab®1-paclitaxel, Bevacizumab, Leucovorin, and Oxaliplatin in Patients With Metastatic Pancreatic Cancer

Who this might be right for
Metastatic Pancreas Adenocarcinoma
Celgene 12
Early research (Phase 1)Study completedNCT00243100
What this trial is testing

Vorinostat and Gemcitabine in Treating Patients With Metastatic or Unresectable Solid Tumors

Who this might be right for
Unspecified Adult Solid Tumor, Protocol Specific
National Cancer Institute (NCI) 21
Large-scale testing (Phase 3)Study completedNCT00026338
What this trial is testing

Gemcitabine With/Out Erlotinib in Unresectable Locally Advanced/Metastatic Pancreatic Cancer

Who this might be right for
Pancreatic Cancer
NCIC Clinical Trials Group 569
Testing effectiveness (Phase 2)UnknownNCT01973101
What this trial is testing

Non-comparative Study of Treatment With Induction Chemotherapy With Cisplatin and Gemcitabine Followed by Chemoradiation or Definitive Chemoradiation in Invasive Locally Advanced Carcinomas of Uterine Cervix.

Who this might be right for
Patients Diagnosed With Advanced Carcinoma of Uterine Cervix t
Instituto do Cancer do Estado de São Paulo 120
Early research (Phase 1)Study completedNCT00626158
What this trial is testing

Gemcitabine and Capecitabine to Treat Patients With Advanced Pancreatic and Biliary Cancers

Who this might be right for
Pancreatic CancerBiliary Cancer
University of California, San Francisco 45
Testing effectiveness (Phase 2)Ended earlyNCT01109615
What this trial is testing

Pemetrexed and Gemcitabine for Treatment Resistant Patients With Metastatic Colorectal Cancer and KRAS Mutations

Who this might be right for
Metastatic Colorectal Cancer
Vejle Hospital 40
Testing effectiveness (Phase 2)Looking for participantsNCT06001658
What this trial is testing

Perioperative Gemcitabine, Cisplatin, and Pembrolizumab in Potentially Resectable Biliary Tract Cancers

Who this might be right for
Billiary Track Cancer
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins 27
Testing effectiveness (Phase 2)WithdrawnNCT00253526
What this trial is testing

Gemcitabine Hydrochloride With or Without Bevacizumab in Treating Patients Who Are Undergoing Surgery for Pancreatic Cancer

Who this might be right for
Adenocarcinoma of the PancreasRecurrent Pancreatic CancerStage I Pancreatic Cancer+2 more
National Cancer Institute (NCI)
Early research (Phase 1)Active Not RecruitingNCT02627443
What this trial is testing

Carboplatin, Gemcitabine Hydrochloride, and Berzosertib in Treating Patients With Recurrent and Metastatic Ovarian, Primary Peritoneal, or Fallopian Tube Cancer

Who this might be right for
Metastatic Fallopian Tube CarcinomaMetastatic Ovarian CarcinomaMetastatic Primary Peritoneal Carcinoma+9 more
National Cancer Institute (NCI) 35
Testing effectiveness (Phase 2)Study completedNCT01601808
What this trial is testing

Clinical Trial Comparing Gemcitabine and Vandetanib Therapy With Gemcitabine Alone in Pancreatic Carcinoma

Who this might be right for
Pancreatic Cancer
University of Liverpool 142
Testing effectiveness (Phase 2)Not Yet RecruitingNCT06591650
What this trial is testing

Gemcitabine Hydrochloride, Cisplatin, Nab-Paclitaxel, and Durvalumab in Treating Patients with Locally Advanced or Metastatic Gallbladder Cancer

Who this might be right for
Gallbladder Cancer Unresectable
Fudan University 33
Testing effectiveness (Phase 2)Study completedNCT02879318
What this trial is testing

Gemcitabine and Nab-Paclitaxel vs Gemcitabine, Nab-Paclitaxel, Durvalumab and Tremelimumab as 1st Line Therapy in Metastatic Pancreatic Adenocarcinoma

Who this might be right for
Pancreatic Adenocarcinoma
Canadian Cancer Trials Group 180
Early research (Phase 1)Study completedNCT01182168
What this trial is testing

Gemcitabine and Split-Dose Cisplatin Plus Everolimus (RAD001) in Patients With Advanced Solid Tumor Malignancies

Who this might be right for
Bladder CancerRenal Pelvis CancerUreter Cancer
Memorial Sloan Kettering Cancer Center 12
Large-scale testing (Phase 3)Study completedNCT04182204
What this trial is testing

Evaluate the Safety and Efficacy of Polatuzumab Vedotin in Combination With Rituximab, Gemcitabine and Oxaliplatin Compared to Rituximab, Gemcitabine and Oxaliplatin Alone in Participants With Relapsed or Refractory Diffuse Large B-Cell Lymphoma

Who this might be right for
Diffuse Large B-Cell Lymphoma
Hoffmann-La Roche 270
Early research (Phase 1)Study completedNCT00599755
What this trial is testing

Phase I Imaging Study Evaluating Gem/Cis or Gem/Carbo for Participants With Non-Small Cell Lung Cancer (MK-0000-083 AM3)

Who this might be right for
CarcinomaNon-small Cell Lung Cancer
Merck Sharp & Dohme LLC 68
Post-approval studies (Phase 4)UnknownNCT04040491
What this trial is testing

PD-1 Antibody, Chidamide, Lenalidomide and Gemcitabine for Peripheral T-cell Lymphoma

Who this might be right for
Peripheral T-cell Lymphoma
Mingzhi Zhang 100
Testing effectiveness (Phase 2)Study completedNCT01303172
What this trial is testing

A Trial Comparing Gemcitabine With and Without IMM-101 in Advanced Pancreatic Cancer

Who this might be right for
Advanced Pancreatic Cancer
Immodulon Therapeutics Ltd 110
Large-scale testing (Phase 3)Study completedNCT04083235
What this trial is testing

Assess the Effectiveness and Safety of Irinotecan Liposome Injection, 5-fluorouracil/Leucovorin Plus Oxaliplatin in Patients Not Previously Treated for Metastatic Pancreatic Cancer, Compared to Nab-paclitaxel+Gemcitabine Treatment

Who this might be right for
Metastatic Adenocarcinoma of the Pancreas
Ipsen 770
Testing effectiveness (Phase 2)Study completedNCT00193076
What this trial is testing

Combination Gemcitabine, Carboplatin With or Without Trastuzumab in Patients With Metastatic Breast Cancer

Who this might be right for
Breast Cancer
SCRI Development Innovations, LLC 96
Load More Results